An anaphylactic reaction is a severe, rapid-onset allergic response that can affect multiple organ systems at once and become life-threatening within minutes. It is driven primarily by the immune system’s mast cells releasing a flood of inflammatory chemicals into the bloodstream, causing symptoms that range from hives and throat swelling to a dangerous drop in blood pressure. The condition is treatable, but its speed and unpredictability make understanding its causes and management genuinely important.
What Happens Inside the Body
The most common form of anaphylaxis follows what immunologists call the IgE-mediated pathway. When someone who has been previously sensitized to an allergen encounters it again, allergen-specific IgE antibodies already sitting on the surface of mast cells and basophils recognize the substance. That recognition triggers those cells to dump their contents, a process called degranulation, releasing histamine and other inflammatory mediators all at once.1PubMed Central. IgE and non-IgE-mediated pathways in anaphylaxis The effect is like pulling the pin on a chemical grenade: blood vessels dilate, airways constrict, and fluid leaks into tissues, all within seconds to minutes.2PubMed Central. Expanding the Immunologic and Neuronal Landscape of IgE-Mediated Anaphylaxis
Not every anaphylactic reaction follows that classic IgE route. Mast cells can also be activated directly by other stimuli, including complement proteins, certain medications, and even physical stimuli like extreme cold. These non-IgE pathways can produce symptoms that look identical to a classic allergic reaction, which is one reason the diagnosis is based on symptoms and clinical presentation rather than on a blood test in the moment.3PubMed. Non-IgE mediated mast cell activation
Common Triggers and How They Shift with Age
The triggers of anaphylaxis break down into a few broad categories: foods, medications, insect stings, and a sizable group where no cause is ever identified. What often surprises people is that the leading trigger depends on age. In children, food is overwhelmingly the most common cause. In adults, insect venom and drugs take the top spots.4PubMed. Causes and risk factors for anaphylaxis
A large study from Singapore illustrating this pattern found that food accounted for about 55% of all anaphylaxis cases, drugs about 20%, and insect stings around 7%. Among children specifically, food caused roughly 72% of reactions compared to 42% in adults, while drug-related anaphylaxis was nearly three times more common in adults than in children. Shellfish was the single most common food trigger, and nonsteroidal anti-inflammatory drugs (like ibuprofen) were the most common medication trigger.5International Archives of Allergy and Immunology. Cause and Clinical Presentation of Anaphylaxis in Singapore: From Infancy to Old Age Those proportions vary somewhat by region and population, but the age-dependent pattern holds broadly across studies.
About 15% of cases in that same cohort were classified as idiopathic, meaning no trigger could be identified despite a thorough workup. That percentage is worth sitting with: roughly one in seven people who have a full-blown anaphylactic reaction never find out what caused it.
Recognizing the Signs
Anaphylaxis typically involves more than one organ system. Skin symptoms like hives, flushing, or swelling are the most visible and show up in the majority of reactions. But the dangerous features involve the airways and the cardiovascular system. Throat tightness, wheezing, difficulty breathing, a sudden drop in blood pressure, dizziness, and loss of consciousness are all red flags. Gastrointestinal symptoms like abdominal cramps, nausea, and vomiting can also accompany a reaction and sometimes appear first, especially in food-triggered cases.
The diagnosis is clinical, meaning doctors rely on the pattern of symptoms rather than waiting for a lab result. Multiple professional organizations have published criteria to help standardize the diagnosis, and while the specifics differ slightly in wording, the core idea is the same: rapid onset of symptoms affecting the skin and at least one other organ system, or a significant drop in blood pressure after exposure to a known allergen.6PubMed Central. Anaphylaxis: Definition and criteria
Cofactors That Make Reactions Worse
One of the less well-known aspects of anaphylaxis is that certain cofactors can amplify a reaction or lower the threshold at which one occurs. You might tolerate a food allergen on a calm day but react severely to the same food if you exercise shortly after eating it, or if you’ve taken ibuprofen, or if you’ve been drinking alcohol. These cofactors don’t cause anaphylaxis on their own, but they can tip a mild reaction into a dangerous one.7PubMed Central. Food allergies and food-induced anaphylaxis: role of cofactors
Physical exercise and alcohol are the two cofactors reported most frequently. In one study of patients with food allergies, about 13% reported more severe symptoms when a cofactor was involved, with exercise accounting for most of those cases and alcohol a distant second. Medications that might act as cofactors, including NSAIDs, beta-blockers, and acid-reducing drugs, were used by about 8% of patients.8PubMed Central. Cofactors in allergic reactions to food: physical exercise and alcohol are the most important This is why some people experience what seems like an inconsistent allergy, reacting to a food one time but not another. The food itself may not be the full explanation.
Epinephrine Is the Treatment
There is exactly one first-line treatment for anaphylaxis: epinephrine (also known as adrenaline), injected into the muscle of the outer thigh. It works on multiple fronts simultaneously. It constricts blood vessels to raise blood pressure, relaxes airway muscles to open breathing passages, and suppresses further mast cell degranulation. No other medication can do all three of those things at once, which is why epinephrine has no substitute in this setting.
The safety profile of intramuscular epinephrine is well established. The most serious cardiovascular side effects, like dangerous heart rhythms, are associated with accidental intravenous injection rather than the standard intramuscular route. A recent safety review concluded that although some adverse events have been reported with intramuscular dosing, there are no absolute contraindications to using it during a life-threatening reaction.9PubMed. Pharmacokinetics and Pharmacodynamics of neffy, Epinephrine Nasal Spray, in Pediatric Allergy Patients Put simply, the risk of withholding epinephrine during anaphylaxis is always greater than the risk of giving it.
Timing matters enormously. Delayed epinephrine use is one of the main drivers of preventable deaths from anaphylaxis.10PubMed Central. Acute Allergic Reactions and Severe Anaphylaxis: Underlying Causes, Management Strategies, and Future Directions People hesitate for all kinds of reasons: uncertainty about whether the reaction is “bad enough,” fear of the needle, or simply not having the auto-injector on hand. That last reason turns out to be the most commonly reported barrier. In one patient survey, 45% of people who owned an auto-injector but didn’t use it during a reaction said the device simply wasn’t available when they needed it.11Annals of Allergy, Asthma & Immunology. Patient-reported barriers to epinephrine auto-injector use and anaphylaxis management
What Changed with Antihistamines and Steroids
For years, many emergency departments routinely gave antihistamines and corticosteroids alongside epinephrine. That practice is shifting. Updated guidelines no longer recommend corticosteroids for the emergency treatment of anaphylaxis, and antihistamines are no longer considered part of the acute management either.12PubMed Central. Evidence update for the treatment of anaphylaxis The reasoning is straightforward: steroids act too slowly to help during an acute reaction, and the evidence that they prevent later symptoms has not held up under scrutiny.
The story with antihistamines is more nuanced. Data from a large Canadian anaphylaxis registry found that patients who received antihistamines before arriving at the emergency department were slightly less likely to have uncontrolled reactions and less likely to be admitted. But patients who received prehospital corticosteroids were actually more likely to need intravenous fluids and be admitted.13PubMed. Managing anaphylaxis: Epinephrine, antihistamines, and corticosteroids: More than 10 years of Cross-Canada Anaphylaxis REgistry data Those are observational findings and could reflect confounding, such as sicker patients being more likely to get steroids, but they align with the general move away from relying on anything other than epinephrine as the core treatment.
Biphasic Reactions and Why Observation Matters
A biphasic reaction is a second wave of anaphylaxis symptoms that occurs hours after the initial episode appears to have resolved. Estimates of how often this happens vary widely, from under 1% to as high as 20%, depending on how the studies define anaphylaxis and how long patients are monitored.14PubMed. Epidemiology, Risk Factors, and Management of Biphasic Anaphylaxis In one large cohort, the rate was about 5%.15PubMed. Risk Factors and Characteristics of Biphasic Anaphylaxis
Several factors increase the risk. Severe initial reactions involving low blood pressure or low oxygen, delayed use of epinephrine, and needing more than one dose of epinephrine all raise the odds of a biphasic event.14PubMed. Epidemiology, Risk Factors, and Management of Biphasic Anaphylaxis In the large cohort study, reactions caused by peanut or tree nut, reactions where the trigger was unknown, and reactions where exercise was a cofactor were also associated with higher biphasic risk.15PubMed. Risk Factors and Characteristics of Biphasic Anaphylaxis This is the main reason emergency departments typically observe patients for several hours after treatment, even when symptoms have fully resolved.
When Epinephrine Alone Is Not Enough
In rare cases, anaphylaxis does not respond adequately to standard intramuscular epinephrine. This is called refractory anaphylaxis, and it poses a serious management challenge. Patients taking beta-blocker medications are at particular risk because beta-blockers can blunt the cardiovascular effects of epinephrine, making it harder for the drug to raise blood pressure and heart rate. Most guidelines recommend intravenous glucagon for these patients, though the evidence base is thin and largely limited to case reports.16PubMed Central. Management of Refractory Anaphylaxis: An Overview of Current Guidelines
One published case describes a patient on beta-blockers whose blood pressure barely responded to adrenaline and fluid resuscitation during anaphylactic shock. A single intravenous dose of glucagon resolved the hypotension immediately.17PubMed Central. Successful treatment of severe adrenaline-resistant anaphylactic shock with glucagon in a patient taking a beta-blocker: a case report The mechanism makes physiological sense: glucagon raises heart output through a pathway that bypasses the beta receptors entirely. But individual case reports aren’t strong evidence, and clinicians generally view glucagon as a rescue option when standard treatment fails rather than a proven therapy.
Epinephrine Nasal Spray
One of the biggest practical barriers to epinephrine use is the needle. Auto-injectors are effective, but plenty of people find them intimidating, and children especially may resist. A nasal spray formulation called neffy has been developed as an alternative delivery method. In adult studies, the nasal spray produced overall higher blood levels of epinephrine than an intramuscular auto-injector, with comparable effects on heart rate and blood pressure.18PubMed. Pharmacokinetic and Pharmacodynamic Profile of Epinephrine Nasal Spray Versus Intramuscular Epinephrine Autoinjector in Healthy Adults
Pediatric data tell a slightly different story. In children, the 1 mg nasal spray produced peak blood levels that were actually higher than in adults, which likely reflects differences in body size and nasal absorption. The blood pressure increase seen in children was lower and gentler than in adults, which from a safety standpoint is reassuring.9PubMed. Pharmacokinetics and Pharmacodynamics of neffy, Epinephrine Nasal Spray, in Pediatric Allergy Patients An integrated analysis across multiple studies found that while the nasal spray’s peak concentration was somewhat lower than some auto-injectors, its effect on blood pressure was comparable or even more pronounced.19PubMed. Pharmacokinetic and pharmacodynamic comparison of epinephrine, administered intranasally and intramuscularly: An integrated analysis For patients who avoid using their auto-injector because of needle anxiety, a nasal spray they’re actually willing to use may end up being more effective in practice than a perfect device that stays in a drawer.
When No Trigger Is Found
Idiopathic anaphylaxis, where repeated episodes occur without an identifiable cause, is a diagnosis of exclusion. It requires ruling out all recognized triggers through skin testing, blood tests for specific IgE, and sometimes supervised allergen challenges. Conditions that mimic anaphylaxis, including certain mast cell disorders and even some rare tumors, also need to be excluded.20PubMed Central. Idiopathic Anaphylaxis The distinction between true anaphylaxis and conditions that look like it can be genuinely difficult; one published case followed a patient treated for recurrent anaphylaxis for 11 years before an entirely different underlying condition was discovered.21PubMed Central. Rare mimic of recurrent anaphylaxis
The good news is that many patients with idiopathic anaphylaxis eventually see their episodes become less frequent. Preventive therapy with a combination of antihistamines and sometimes corticosteroids can reduce the frequency, and in many cases the regular medications can be tapered after about a year.20PubMed Central. Idiopathic Anaphylaxis
Confirming Anaphylaxis After the Fact
Because anaphylaxis is diagnosed by its symptoms in real time, there’s sometimes uncertainty afterward about whether a reaction truly was anaphylaxis. Serum tryptase, a chemical released by mast cells, can help. If a blood sample drawn one to two hours after the reaction shows elevated tryptase compared to a baseline level taken days or weeks later, that supports the diagnosis. In one study, tryptase measured within the first two hours averaged about 19 µg/L, significantly higher than baseline levels below 11.4 µg/L. Tryptase also correlated with severity: higher-grade reactions produced higher levels.22International Archives of Allergy and Immunology. Usefulness and Limitations of Sequential Serum Tryptase for the Diagnosis of Anaphylaxis in 102 Patients
The limitation is that tryptase doesn’t rise in every case. In that same study, it remained normal in more than a third of confirmed anaphylaxis episodes. A Korean hospital study found that using a formula comparing peak tryptase to the patient’s own baseline improved the detection rate to about 71%, compared to only 53% when using a fixed cutoff.23PubMed Central. Causes and Diagnostic Usefulness of Tryptase Measurements for Anaphylaxis in a Korean Tertiary Care General Hospital A normal tryptase level does not rule out anaphylaxis, particularly in food-triggered reactions, which tend to produce lower tryptase elevations than venom or drug reactions. Clinicians treat it as a helpful but imperfect confirmation tool.
Long-term Prevention for Venom Allergies
For people whose anaphylaxis is triggered by insect stings, venom immunotherapy offers something close to a cure. The therapy involves regular injections of gradually increasing doses of the relevant venom over months to years, and it works remarkably well. A Cochrane review found that only about 3% of people who completed venom immunotherapy had a subsequent allergic reaction to a sting, compared to roughly 40% of untreated individuals.24PubMed Central. Venom immunotherapy for preventing allergic reactions to insect stings That kind of effect size is unusual in allergy treatment and makes venom immunotherapy one of the strongest recommendations in the field.
Immunotherapy for food allergies exists as well but is in a different place scientifically. Oral immunotherapy for peanut allergy, for instance, can raise the threshold at which a reaction occurs, but it doesn’t eliminate the allergy and requires ongoing daily dosing. It also carries a meaningful risk of allergic reactions during treatment itself. The landscape is evolving quickly, but for now, strict avoidance plus carrying epinephrine remains the standard approach for most food-triggered anaphylaxis.
Why Allergic Immunity Exists at All
It seems like a design flaw that the immune system can kill you in response to a peanut. One line of research argues it’s actually a defense system that misfires. The IgE antibody pathway, the same one that drives anaphylaxis, appears to have evolved as a defense against venoms, parasites, and environmental toxins. The rapid vascular response that drops your blood pressure during anaphylaxis may have originally served to flush toxins from tissues, and the airway constriction may have helped prevent inhalation of harmful substances.25PubMed Central. Allergic host defences In this framing, anaphylaxis is what happens when a system designed for a measured local defense goes catastrophically systemic. The immune system isn’t broken; it’s just using a weapon built for precision warfare in a context where the target is harmless and the response is wildly disproportionate.